LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the Middle East. Read More
| Price | 66.50p on 04-08-2026 at 07:00:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 70.00p |
| Sell | 63.00p |
| Last Trade: | Sell 4,495.00 at 65.60p |
| Day's Volume: | 0 |
| Last Close: | 66.50p |
| Open: | 66.50p |
| ISIN: | GB00B0BRN552 |
| Day's Range | 66.50p - 66.50p |
| 52wk Range: | 57.00p - 128.00p |
| Market Capitalisation: | £51.24m |
| VWAP: | 0.00p |
| Shares in Issue: | 77.05m |
Sector: Software and Computing
Listed In: FTSE AIM All-Share,
Bango (BGO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 4,495 | 65.60p | Ordinary |
15:57:47 - 03-Aug-26 |
| Sell* | 500 | 64.00p | Ordinary |
13:31:43 - 03-Aug-26 |
| Sell* | 5,000 | 64.00p | Ordinary |
12:18:35 - 03-Aug-26 |
| Sell* | 340 | 64.00p | Ordinary |
10:30:50 - 03-Aug-26 |
| Sell* | 5 | 63.00p | SI Trade |
10:10:35 - 03-Aug-26 |
| Sell* | 4,563 | 65.65p | Ordinary |
08:46:34 - 03-Aug-26 |
| Sell* | 1,679 | 65.73p | Ordinary |
15:44:50 - 31-Jul-26 |
| Sell* | 2,275 | 65.75p | Ordinary |
15:44:11 - 31-Jul-26 |
| Sell* | 2,514 | 65.93p | Ordinary |
15:42:18 - 31-Jul-26 |
| Sell* | 3,785 | 65.93p | Ordinary |
15:41:38 - 31-Jul-26 |
Bango (BGO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Jul 2026 5:36 pm | RNS | Director/PDMR Shareholding |
| 17th Jul 2026 5:22 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 9th Jul 2026 7:00 am | RNS | 1H26 Trading Statement |
| 26th Jun 2026 7:00 am | RNS | Directorate change |
| 25th Jun 2026 4:18 pm | RNS | Result of AGM |
| 25th Jun 2026 8:00 am | RNS-R | Turkcell select Bango for subscription bundling |
| 22nd Jun 2026 2:17 pm | RNS | Director/PDMR Shareholding |
| 20th May 2026 7:00 am | RNS | Notice of AGM |
| 19th May 2026 6:14 pm | RNS | Director/PDMR Shareholding |